Streetbeat News

Price Targets

FSLY

RBC Capital analyst Rishi Jaluria maintains an 'Underperform' rating on Fastly (NYSE:FSLY) and raises the price target from $11 to $12.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 1:32 pm

BLDR

RBC Capital analyst Mike Dahl maintains an Outperform rating on Builders FirstSource (NYSE:BLDR) and raises the price target from $162 to $188.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 1:32 pm

CVS

RBC Capital analyst Ben Hendrix has maintained an 'Outperform' rating on CVS Health (NYSE:CVS), but lowered the price target from $102 to $91.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 1:32 pm

FLS

RBC Capital analyst Deane Dray has maintained a 'Sector Perform' rating on Flowserve (NYSE:FLS) and raised the price target from $40 to $42.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 1:32 pm

UPWK

Upwork's shares are trading higher following the release of its Q2 financial results, which exceeded expectations. The company also issued FY23 adjusted EPS guidance above estimates. JPM Securities and Needham have subsequently raised their price targets on the stock.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 1:32 pm

ACAD

Canaccord Genuity analyst Sumant Kulkarni maintains a 'Buy' rating on ACADIA Pharmaceuticals but lowers the price target from $39 to $38.

Portfolio Pulse from jenniferd'souza@benzinga.com

August 04, 2023 | 1:32 pm

RITM

Rithm Capital (NYSE:RITM) has received five somewhat bullish analyst ratings in the last quarter, with no bearish or indifferent ratings. The average 12-month price target for RITM has increased by 8.42% from the previous average, now standing at $11.2.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 1:32 pm

TSX:POU

RBC Capital analyst Michael Harvey maintains a 'Sector Perform' rating on Paramount Resources and raises the price target from C$35 to C$37.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 1:32 pm

ADC

RBC Capital analyst Brad Heffern maintains an Outperform rating on Agree Realty (NYSE:ADC) but lowers the price target from $75 to $74.

Portfolio Pulse from richadhand@benzinga.com

August 04, 2023 | 1:31 pm

CERE

Morgan Stanley analyst Matthew Harrison maintains an Overweight rating on Cerevel Therapeutics Hldg (NASDAQ:CERE) but lowers the price target from $46 to $42.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 1:31 pm